Phlorizin

CAS No. 60-81-1

Phlorizin ( Floridzin; NSC 2833 )

Catalog No. M18883 CAS No. 60-81-1

Phlorizin is a non-selective SGLT inhibitor found in apple, for hSGLT1( Ki=300 nM) and hSGLT2( Ki=39 nM) .

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 41 In Stock
1G 50 In Stock

Biological Information

  • Product Name
    Phlorizin
  • Note
    Research use only, not for human use.
  • Brief Description
    Phlorizin is a non-selective SGLT inhibitor found in apple, for hSGLT1( Ki=300 nM) and hSGLT2( Ki=39 nM) .
  • Description
    Phlorizin is a non-selective SGLT inhibitor found in apple, for hSGLT1( Ki=300 nM) and hSGLT2( Ki=39 nM) .
  • Synonyms
    Floridzin; NSC 2833
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    hSGLT1; hSGLT2
  • Research Area
    Metabolic Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    60-81-1
  • Formula Weight
    436.42
  • Molecular Formula
    C21H24O10
  • Purity
    98%
  • Solubility
    DMSO : ≥ 50 mg/mL 114.57 mM H2O : 1 mg/mL2.29 mM;
  • SMILES
    O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)c1c(c(cc(c1)O)O)C(=O)CCc1ccc(cc1)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Taton J, et al. Endokrynol Pol, 2010, 61(3), 303-310.
molnova catalog
related products
  • (2-phenylethyl)hydra...

    (2-phenylethyl)hydrazine dihydrochloride is a chemical compound.

  • Ingenol

    Ingenol mebutate is an effective treatment for actinic keratosis. 2. Formulating novel derivatives from Ingenol esters may be an innovative approach to develop new lead compounds to reactivate latent HIV.

  • VUT-MK142

    VUT-MK142 is a new cardiomyogenic small molecule promoting the differentiation of pre-cardiac mesoderm into cardiomyocytes,which may be useful to differentiate stem cells into cardiomyocytes for cardiac repair.VUT-MK142 was identified as the most promising candidate with respect to cardiomyogenic activity.?